IBDEI2LT ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,433,0)
 ;;=EXAMINATIONS^4^33
 ;;^UTILITY(U,$J,358.4,434,0)
 ;;=EXPOSURES^5^33
 ;;^UTILITY(U,$J,358.4,435,0)
 ;;=IMMUNIZATIONS^6^33
 ;;^UTILITY(U,$J,358.4,436,0)
 ;;=CARDIOVASCULAR EXERCISE^2^33
 ;;^UTILITY(U,$J,358.4,437,0)
 ;;=COUNSELING^3^33
 ;;^UTILITY(U,$J,358.4,438,0)
 ;;=MUSCLE CONDITIONING EXERCISE^8^33
 ;;^UTILITY(U,$J,358.4,439,0)
 ;;=NEW PATIENT^2^34
 ;;^UTILITY(U,$J,358.4,440,0)
 ;;=ESTABLISHED PATIENT^1^34
 ;;^UTILITY(U,$J,358.4,441,0)
 ;;=CONSULTATIONS^3^34
 ;;^UTILITY(U,$J,358.4,442,0)
 ;;=ENDOCRINE DX^1^35
 ;;^UTILITY(U,$J,358.4,443,0)
 ;;=BIOPSIES^1^36
 ;;^UTILITY(U,$J,358.4,444,0)
 ;;=INJECTIONS^2^36
 ;;^UTILITY(U,$J,358.4,445,0)
 ;;=OTHER^3^36
 ;;^UTILITY(U,$J,358.4,446,0)
 ;;=PROLONGED CLINICAL STAFF SERVICES^4^36
 ;;^UTILITY(U,$J,358.4,447,0)
 ;;=HEAD AND NECK-MISCELLANEOUS^1^37
 ;;^UTILITY(U,$J,358.4,448,0)
 ;;=NOSE AND SINUSES^3^37
 ;;^UTILITY(U,$J,358.4,449,0)
 ;;=ORAL CAVITY^4^37
 ;;^UTILITY(U,$J,358.4,450,0)
 ;;=OTOLOGY^5^37
 ;;^UTILITY(U,$J,358.4,451,0)
 ;;=PHARYNX AND LARYNX^6^37
 ;;^UTILITY(U,$J,358.4,452,0)
 ;;=MISCELLANEOUS PROCEDURES^2^37
 ;;^UTILITY(U,$J,358.4,453,0)
 ;;=PROLONGED CLINICAL STAFF SERVICES^7^37
 ;;^UTILITY(U,$J,358.4,454,0)
 ;;=ESTABLISHED PATIENT^1^38
 ;;^UTILITY(U,$J,358.4,455,0)
 ;;=CONSULTATIONS^3^38
 ;;^UTILITY(U,$J,358.4,456,0)
 ;;=NEW PATIENT^2^38
 ;;^UTILITY(U,$J,358.4,457,0)
 ;;=POST OP^4^38
 ;;^UTILITY(U,$J,358.4,458,0)
 ;;=ALIMENTARY TRACT^1^39
 ;;^UTILITY(U,$J,358.4,459,0)
 ;;=FRACTURES^2^39
 ;;^UTILITY(U,$J,358.4,460,0)
 ;;=NEOPLASMS^4^39
 ;;^UTILITY(U,$J,358.4,461,0)
 ;;=RESPIRATORY TRACT^6^39
 ;;^UTILITY(U,$J,358.4,462,0)
 ;;=OTOLOGY^5^39
 ;;^UTILITY(U,$J,358.4,463,0)
 ;;=OTHER HEAD AND NECK^7^39
 ;;^UTILITY(U,$J,358.4,464,0)
 ;;=METASTATIC SITES^3^39
 ;;^UTILITY(U,$J,358.4,465,0)
 ;;=REFRACTION^1^40
 ;;^UTILITY(U,$J,358.4,466,0)
 ;;=GLASSES/CONTACT LENSES^2^40
 ;;^UTILITY(U,$J,358.4,467,0)
 ;;=SPECIAL OPHTHALMIC SERVICES^4^40
 ;;^UTILITY(U,$J,358.4,468,0)
 ;;=ANTERIOR SEGMENT^2^41
 ;;^UTILITY(U,$J,358.4,469,0)
 ;;=GLAUCOMA^4^41
 ;;^UTILITY(U,$J,358.4,470,0)
 ;;=INFECTIONS^5^41
 ;;^UTILITY(U,$J,358.4,471,0)
 ;;=LENS/CATARACT^6^41
 ;;^UTILITY(U,$J,358.4,472,0)
 ;;=LOW VISION/BLINDNESS^7^41
 ;;^UTILITY(U,$J,358.4,473,0)
 ;;=DIABETES^3^41
 ;;^UTILITY(U,$J,358.4,474,0)
 ;;=MOST COMMON & POST OP^1^41
 ;;^UTILITY(U,$J,358.4,475,0)
 ;;=NEUROLOGIC EYE DISEASE^8^41
 ;;^UTILITY(U,$J,358.4,476,0)
 ;;=ORBIT/EYELID/LACRIMAL^9^41
 ;;^UTILITY(U,$J,358.4,477,0)
 ;;=REFRACTION^10^41
 ;;^UTILITY(U,$J,358.4,478,0)
 ;;=RETINA/VITREOUS^11^41
 ;;^UTILITY(U,$J,358.4,479,0)
 ;;=STRABISMUS^12^41
 ;;^UTILITY(U,$J,358.4,480,0)
 ;;=SYSTEMIC/TRAUMA/OTHER^13^41
 ;;^UTILITY(U,$J,358.4,481,0)
 ;;=NEW PATIENT^3^42
 ;;^UTILITY(U,$J,358.4,482,0)
 ;;=ESTABLISHED PATIENT^2^42
 ;;^UTILITY(U,$J,358.4,483,0)
 ;;=CONSULTATIONS^4^42
 ;;^UTILITY(U,$J,358.4,484,0)
 ;;=EYE CODES^1^42
 ;;^UTILITY(U,$J,358.4,485,0)
 ;;=REFRACTION^8^43
 ;;^UTILITY(U,$J,358.4,486,0)
 ;;=GLASSES/CONTACT LENSES^2^43
 ;;^UTILITY(U,$J,358.4,487,0)
 ;;=SPECIAL OPHTHALMIC SERVICES^10^43
 ;;^UTILITY(U,$J,358.4,488,0)
 ;;=PROCEDURES^7^43
 ;;^UTILITY(U,$J,358.4,489,0)
 ;;=LASER PROCEDURES^4^43
 ;;^UTILITY(U,$J,358.4,490,0)
 ;;=RETINA PROCEDURES^9^43
 ;;^UTILITY(U,$J,358.4,491,0)
 ;;=MEDICATIONS^5^43
 ;;^UTILITY(U,$J,358.4,492,0)
 ;;=INJECTIONS^3^43
 ;;^UTILITY(U,$J,358.4,493,0)
 ;;=EDUCATION/COUNSELING^1^43
 ;;^UTILITY(U,$J,358.4,494,0)
 ;;=PRE-OP^6^43
 ;;^UTILITY(U,$J,358.4,495,0)
 ;;=ANTERIOR SEGMENT^2^44
 ;;^UTILITY(U,$J,358.4,496,0)
 ;;=GLAUCOMA^4^44
 ;;^UTILITY(U,$J,358.4,497,0)
 ;;=INFECTIONS^5^44
